In addition to wAIHA, sovleplenib is also being studied in immune thrombocytopenia (“ITP”). Positive results from ESLIM-01 (NCT05029635), a Phase III trial in China of sovleplenib in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback